Insider · CIK 0001760391

FEES JESSICA

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001760391

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-09-08	Surface Oncology, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−102K sh	—	—	0
2023-09-08	Surface Oncology, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−150K sh	—	—	0
2023-08-01	Surface Oncology, Inc.S Sale	Chief Financial Officer	SSale	−9,434 sh	$0.94	−$8,867.96	101,915
2023-03-01	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000
2022-08-03	Surface Oncology, Inc.S Sale	Chief Financial Officer	SSale	−5,980 sh	$1.72	−$10.3K	111,349
2022-03-01	Surface Oncology, Inc.A Award	Chief Financial Officer	AAward	+38K sh	—	—	117,329
2022-03-01	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+108K sh	—	—	108,000
2021-07-21	Surface Oncology, Inc.S Sale	Chief Financial Officer	SSale	−19.9K sh	$6.10	−$121K	79,329
2021-05-03	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+30K sh	—	—	30,000
2021-03-01	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+68K sh	—	—	68,000
2021-02-08	Surface Oncology, Inc.S Sale	Chief Financial Officer	SSale	−1,500 sh	$12.45	−$18.7K	99,183
2021-02-01	Surface Oncology, Inc.S Sale	Chief Financial Officer	SSale	−1,500 sh	$11.19	−$16.8K	100,683
2020-11-25	Surface Oncology, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+227 sh	$4.14	+$938.872	101,027
2020-11-25	Surface Oncology, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+173 sh	$4.27	+$738.71	101,200
2020-11-25	Surface Oncology, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+982 sh	$5.41	+$5,314.584	102,182
2020-11-25	Surface Oncology, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1 sh	$4.27	+$4.27	102,183
2020-11-25	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−227 sh	—	—	455
2020-11-25	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−173 sh	—	—	13,905
2020-11-25	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−982 sh	—	—	2,654
2020-11-25	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1 sh	—	—	25,999
2020-10-28	Surface Oncology, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,773 sh	$4.14	+$19.7K	100,678
2020-10-28	Surface Oncology, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+122 sh	$4.27	+$520.94	100,800
2020-10-28	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,773 sh	—	—	682
2020-10-28	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−122 sh	—	—	14,078
2020-02-03	Surface Oncology, Inc.A Award	Chief Financial Officer	AAward	+45K sh	—	—	95,905
2020-02-03	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+45K sh	—	—	45,000
2019-04-01	Surface Oncology, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,728 sh	$0.35	+$960.256	50,905
2019-04-01	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,728 sh	—	—	0
2019-03-01	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+14.2K sh	—	—	14,200
2019-03-01	Surface Oncology, Inc.Stockk Option (Right to Buy)A Award	Chief Financial Officer	AAward	+26K sh	—	—	26,000
2019-01-04	Surface Oncology, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,818 sh	$0.35	+$639.936	47,722
2019-01-04	Surface Oncology, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+455 sh	$4.14	+$1,881.88	48,177
2019-01-04	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,818 sh	—	—	2,728
2019-01-04	Surface Oncology, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−455 sh	—	—	5,455

Recent filings

Accepted (ET)
Sep 84
FEES JESSICA0001209191-23-048764
SEC(opens sec.gov)
Aug 114
FEES JESSICA0001209191-23-045495
SEC(opens sec.gov)
Mar 34
FEES JESSICA0001209191-23-016049
SEC(opens sec.gov)
Aug 54
FEES JESSICA0001209191-22-044672
SEC(opens sec.gov)
Mar 34
FEES JESSICA0001209191-22-015964
SEC(opens sec.gov)
Jan 144
FEES JESSICA0001209191-22-003399
SEC(opens sec.gov)
May 54
FEES JESSICA0000899243-21-018401
SEC(opens sec.gov)
Mar 34
FEES JESSICA0001209191-21-017475
SEC(opens sec.gov)
Feb 94
FEES JESSICA0001209191-21-009058
SEC(opens sec.gov)
Feb 34
FEES JESSICA0001209191-21-007549
SEC(opens sec.gov)
Nov 274
FEES JESSICA0001209191-20-060665
SEC(opens sec.gov)

Companies

Surface Oncology, Inc.Chief Financial Officer

Address

C/O SURFACE ONCOLOGY, INC. 50 HAMPSHIRE STREET, 8TH FLOOR

CAMBRIDGE, MA, 02139